Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Common Stock | Options Exercise | +1.67K | +0.68% | 248K | Oct 15, 2024 | Direct | F1 | ||
transaction | GBIO | Common Stock | Tax liability | -$1.19K | -492 | -0.2% | $2.42 | 247K | Oct 15, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -1.67K | -10% | $0.00 | 15.1K | Oct 15, 2024 | Common Stock | 1.67K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
F2 | On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. |